sepsis Related News
Could genes be the answer to personalised sepsis treatment?
Sepsis is a life-threatening infection and affects people in a multitude of ways depending on genetic makeup. A team of researchers has uncovered how...
Sepsis prevention: The alliance of vaccinations, sanitation, and the vaccine cold chain
Sepsis is a severe bodily reaction to infection, which can cause fever, breathlessness, disorientation, tissue damage, and organ failure, among other symptoms.
While bacterial infections...
An anticancer drug could be used as sepsis treatment
Anticancer can drugs can limit inflammation, meaning they could be used as a sepsis treatment, according to researchers in Portugal.
According to researchers from Instituto...
Inflammatix: Advancing diagnostics for acute infection and sepsis
Inflammatix explores the unmet needs associated with the diagnosis of acute infection and sepsis and how new diagnostic technologies are helping to improve the...
Sepsis and healthcare-associated infections
The Global Sepsis Alliance reflects on the progress made in tackling sepsis and the hurdles that remain in relation to healthcare-associated infections.
The term sepsis...
Why sepsis awareness matters in the fight to save lives
With early diagnosis being vital in the treatment of sepsis, Sepsis Alliance shares how they are working to raise awareness of the condition’s associated...
AI-based early warning system for sepsis can improve patient outcomes
An artificial intelligence (AI) algorithm for detecting sepsis warning signs has been proven to increase survival rates and reduce hospital stays.
In a study by...
Study offers insight into treatment of sepsis and chemotherapy damage
In a new study, researchers have made significant advances towards devising a novel treatment for sepsis, which they believe could also be extended to...
New partnership announced today is set to reduce the impact of sepsis in the UK
Beckman Coulter, the global leader in clinical diagnostics, announces today its partnership with South West London Pathology (SWLP) to reduce the impact of sepsis in...
Breakthrough for sepsis with new tech for measuring white blood cells
A new way of measuring white blood cell function offers better insights to help patients with sepsis.
The development of this technology for measuring white...
Adrenomed AG conference participation schedule announced
German vascular integrity company Adrenomed AG has announced it will participate in four upcoming conferences across Europe.
Adrenomed AG, a private clinical stage biopharmaceutical firm...
Time to look for therapeutic targets in sepsis
Sepsis is a medical condition that few patients have heard of and most doctors dread – But could scientists bring about new therapeutic targets...
Adrenomed’s Adrecizumab: the septic shock study that’s passed analysis
Adrenomed’s septic shock study introduces Adrecizumab, a first-in-class antibody targeting Adrenomedullin, to restore and maintain vascular integrity in early septic shock.
Hennigsdorf, Germany, 21 March...
Treating septic shock: Wellington and HBM invest millions in Adrenomed
Vascular integrity company, Adrenomed, announces the closing of a €24m financing led by top-tier investors Wellington and HBM, potentially being one step closer to...